Herein, we report a novel series of pyrano[3,2-c]quinoline-3-carboxylates combating the staphylococcal infection-lung cancer interplay by inhibiting both DNA gyrase and topoisomerase II with apoptosis induction ability. The gene discussed is TOP2A; the disease is staphylococcal infection.